Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Digoxin products are in shortage in Canada (3 of 9 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A cardiac glycoside used to treat heart failure and certain irregular heart rhythms.
Products affected
3 / 9
In shortage since
Mar 10, 2017
Reports on file
23
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-DIGOXIN
0.25MG · TABLET · APOTEX INC
DIN 02281201 · since Mar 10, 2017, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-DIGOXIN
0.125MG · TABLET · APOTEX INC
DIN 02281228 · since Mar 10, 2017, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-DIGOXIN
0.0625MG · TABLET · APOTEX INC
DIN 02281236 · since Mar 10, 2017, no end estimate · Disruption of the manufacture of the drug.
Resolved
JAMP DIGOXIN
0.0625MG · TABLET · JAMP PHARMA CORPORATION
DIN 02498502 · ended Feb 13, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP DIGOXIN
0.125MG · TABLET · JAMP PHARMA CORPORATION
DIN 02498510 · ended Jan 30, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP DIGOXIN
0.0625MG · TABLET · JAMP PHARMA CORPORATION
DIN 02498502 · ended Jun 20, 2024 · Disruption of the manufacture of the drug.
Resolved
JAMP DIGOXIN
0.125MG · TABLET · JAMP PHARMA CORPORATION
DIN 02498510 · ended Mar 21, 2024 · Demand increase for the drug.
Resolved
PMS-DIGOXIN
0.05MG · SOLUTION · PHARMASCIENCE INC
DIN 02242320 · ended Oct 6, 2023 · Disruption of the manufacture of the drug.
Resolved
TOLOXIN
0.05MG · SOLUTION · PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN 02242320 · ended Dec 15, 2021 · Shortage of an inactive ingredient or component.
Resolved
TOLOXIN
0.0625MG · TABLET · PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN 02335700 · ended Nov 12, 2020 · Disruption of the manufacture of the drug.
Resolved
TOLOXIN
0.125MG · TABLET · PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN 02335719 · ended May 7, 2020 · Limited Quantities Available
Resolved
TOLOXIN
0.0625MG · TABLET · PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN 02335700 · ended Feb 28, 2020 · Disruption of the manufacture of the drug.
Showing 12 of 23 reports. All reports are on file with Health Canada.
What's happening
Digoxin is currently affected by 3 active shortage reports filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Digoxin is classified under “CARDIAC GLYCOSIDES” (ATC C01AA).
Recent changes
No changes recorded yet.
Common questions
What is Digoxin used for?
A cardiac glycoside used to treat heart failure and certain irregular heart rhythms.
When will Digoxin be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Digoxin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.